Empowering physicians in global healthcare organizations to reduce polypharmacy-related drug relapse (DRP) by partnering with patients, families, physician collaboration, and schools to develop, implement, test , improve and teach speech and support. Patient safety. Polypharmacy, in which a person uses multiple medications at the same time, is common among many patients, including patients who do not have a doctor, patients with mental disorders, patients with multiple illnesses, and the elderly. We emphasize the importance of multi-group collaboration to explain the effort.
Identify barriers and factors contributing to compliance with regulatory requirements.
Develop strategies to resolve issues and improve staffing for decommissioning.